Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Breeze Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Breeze Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 87 · Grade C

Breeze Meds

Visit Breeze Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 76 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Breeze Meds a bad call — it's best for readers starting at a low dose who want nothing charged until a provider has approved them. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
70
Supply Reliability
95
82
Transparency
90
60
Access Breadth
93
88
Clinical Oversight
92
78
Track Record
88
76
CoreAge RxBrief Score 94 · 76Breeze Meds

Price, coverage & the tracker

CoreAge RxBreeze Meds
Brief Score94/100 (A)76/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199/mo injectable (list $249) · $299/mo oral — the 3- and 6-month bundles cost MORE per month ($249 and $208); only the 12-month prepay is lower, at $191.50 ($2,298)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$299/mo injectable (list $399) · $399/mo oral — the 3- and 6-month bundles cost MORE per month ($356 and $320); the 12-month prepay is $291.50 ($3,498)

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Breeze Meds: Every published figure is quoted at the LOWEST dose — the funnel says higher doses may cost more, so these are floors.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.